Altamira Therapeutics Ltd. Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement
Altamira Therapeutics Ltd. (CYTOF) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement of CHF 26.28 as of 2018-12-31, per its 20-F filed 2019-03-14.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement · last filed 2019-03-14
- 2018-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement 26.28 CHF.
- 2017-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement 4.48 CHF.
- 2016-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement 4.56 CHF.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement |
|---|---|
| 2018-12-31 | 26.28 CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 4.48 CHF 20-F · filed 2018-03-22 |
| 2016-12-31 | 4.56 CHF 20-F · filed 2018-03-22 |